Your browser doesn't support javascript.
Addressing global disparities in blood pressure control: perspectives of the International Society of Hypertension.
Schutte, Aletta E; Jafar, Tazeen H; Poulter, Neil R; Damasceno, Albertino; Khan, Nadia A; Nilsson, Peter M; Alsaid, Jafar; Neupane, Dinesh; Kario, Kazuomi; Beheiry, Hind; Brouwers, Sofie; Burger, Dylan; Charchar, Fadi J; Cho, Myeong Chan; Guzik, Tomasz J; Haji Al-Saedi, Ghazi F; Ishaq, Muhammad; Itoh, Hiroshi; Jones, Erika S W; Khan, Taskeen; Kokubo, Yoshihiro; Kotruchin, Praew; Muxfeldt, Elizabeth; Odili, Augustine; Patil, Mansi; Ralapanawa, Udaya; Romero, Cesar A; Schlaich, Markus P; Shehab, Abdulla; Mooi, Ching Siew; Steckelings, U Muscha; Stergiou, George; Touyz, Rhian M; Unger, Thomas; Wainford, Richard D; Wang, Ji-Guang; Williams, Bryan; Wynne, Brandi M; Tomaszewski, Maciej.
  • Schutte AE; School of Population Health, University of New South Wales, Kensington Campus, High Street, Sydney 2052 NSW, Australia; The George Institute for Global Health, King Street, Newton, Sydney NSW 2052, Australia.
  • Jafar TH; Hypertension in Africa Research Team, SAMRC Unit for Hypertension and Cardiovascular Disease; North-West University, Hoffman Street, Potchefstroom 2520, South Africa.
  • Poulter NR; SAMRC Development Pathways for Health Research Unit, School of Clinical Medicine, University of the Witwatersrand, 1 Jan Smuts Ave, Braamfontein, Johannesburg, 2000, South Africa.
  • Damasceno A; Program in Health Services and Systems Research, Duke-NUS Medical School, Department of Renal Medicine, 8 College Rd., Singapore 169857, Singapore.
  • Khan NA; Duke Global Health Institute, Duke University, 310 Trent Dr, Durham, NC 27710, USA.
  • Nilsson PM; Imperial Clinical Trials Unit, School of Public Health, Imperial College London, London W12 7RH, UK.
  • Alsaid J; Faculty of Medicine, Eduardo Mondlane University, 3453 Avenida Julius Nyerere, Maputo, Mozambique.
  • Neupane D; Department of Medicine, University of British Columbia, Vancouver, British Columbia, Canada.
  • Kario K; Center for Health Evaluation and Outcomes Sciences, Vancouver, British Columbia, Canada.
  • Beheiry H; Department of Clinical Sciences, Skane University Hospital, Lund University, Malmö, Sweden.
  • Brouwers S; Ochsner Health System, New Orleans, Louisiana, USA.
  • Burger D; Queensland University, Brisbane, Queensland, Australia.
  • Charchar FJ; Department of International Health, Johns Hopkins Bloomberg School of Public Health, Johns Hopkins University, Baltimore, MD, USA.
  • Cho MC; Division of Cardiovascular Medicine, Department of Medicine, Jichi Medical University School of Medicine, Tochigi, Japan.
  • Guzik TJ; International University of Africa, Khartoum, Sudan.
  • Haji Al-Saedi GF; Department of Cardiology, Cardiovascular Center Aalst, OLV Clinic Aalst, Aalst, Belgium.
  • Ishaq M; Department of Experimental Pharmacology, Faculty of Medicine and Pharmacy, Vrije Universiteit Brussel, Brussels, Belgium.
  • Itoh H; Kidney Research Centre, Ottawa Hospital Research Institute, Department of Cellular and Molecular Medicine, University of Ottawa, Ottawa, Ontario, Canada.
  • Jones ESW; Health Innovation and Transformation Centre, Federation University, Ballarat, Victoria, Australia.
  • Khan T; Department of Physiology and Anatomy, University of Melbourne, Melbourne, Victoria, Australia.
  • Kokubo Y; Department of Internal Medicine, College of Medicine, Chungbuk National University, Cheongju, Korea.
  • Kotruchin P; Institute of Cardiovascular and Medical Sciences, University of Glasgow, Glasgow, UK.
  • Muxfeldt E; Baghdad College of Medicine, Baghdad, Iraq.
  • Odili A; Pakistan Hypertension League, Karachi, Pakistan.
  • Patil M; Department of Endocrinology, Metabolism and Nephrology, School of Medicine, Keio University, 35 Shinanomachi, Shinjuku-ku, Tokyo 160-8585, Japan.
  • Ralapanawa U; Division of Nephrology and Hypertension, Groote Schuur Hospital and Kidney and Hypertension Research Unit, University of Cape Town, Cape Town, South Africa.
  • Romero CA; Department of Public Health Medicine, University of Pretoria, Pretoria, South Africa.
  • Schlaich MP; Department of Preventive Cardiology, National Cerebral and Cardiovascular Center, Osaka, Japan.
  • Shehab A; Department of Emergency Medicine, Faculty of Medicine, Khon Kaen University, Khon Kaen, Thailand.
  • Mooi CS; University Hospital Clementino Fraga Filho, Hypertension Program, Universidade Federal do Rio de Janeiro, Brazil.
  • Steckelings UM; Circulatory Health Research Laboratory, College of Health Sciences, University of Abuja, Abuja, Nigeria.
  • Stergiou G; Department of Nutrition and Dietetics, Asha Kiran JHC Hospital, Chinchwad, India.
  • Touyz RM; Faculty of Medicine, University of Peradeniya, Kandy, Central Province, Sri Lanka.
  • Unger T; Renal Division, Department of Internal Medicine, Emory University School of Medicine, Atlanta, GA, USA.
  • Wainford RD; Dobney Hypertension Centre, School of Medicine, Royal Perth Hospital Unit and RPH Research Foundation, The University of Western Australia, Perth, Australia.
  • Wang JG; Department of Cardiology, Royal Perth Hospital, Perth, Western Australia, Australia.
  • Williams B; Department of Nephrology, Royal Perth Hospital, Perth, Western Australia, Perth, Western Australia, Australia.
  • Wynne BM; College of Medicine and Health Sciences, United Arab Emirates University, Al Ain, United Arab Emirates.
  • Tomaszewski M; Department of Family Medicine, Faculty of Medicine and Health Sciences, Universiti Putra Malaysia, Malaysia.
Cardiovasc Res ; 2022 Oct 11.
Article in English | MEDLINE | ID: covidwho-2280272
ABSTRACT
Raised blood pressure (BP) is the leading cause of preventable death in the world. Yet, its global prevalence is increasing, and it remains poorly detected, treated, and controlled in both high- and low-resource settings. From the perspective of members of the International Society of Hypertension based in all regions, we reflect on the past, present, and future of hypertension care, highlighting key challenges and opportunities, which are often region-specific. We report that most countries failed to show sufficient improvements in BP control rates over the past three decades, with greater improvements mainly seen in some high-income countries, also reflected in substantial reductions in the burden of cardiovascular disease and deaths. Globally, there are significant inequities and disparities based on resources, sociodemographic environment, and race with subsequent disproportionate hypertension-related outcomes. Additional unique challenges in specific regions include conflict, wars, migration, unemployment, rapid urbanization, extremely limited funding, pollution, COVID-19-related restrictions and inequalities, obesity, and excessive salt and alcohol intake. Immediate action is needed to address suboptimal hypertension care and related disparities on a global scale. We propose a Global Hypertension Care Taskforce including multiple stakeholders and societies to identify and implement actions in reducing inequities, addressing social, commercial, and environmental determinants, and strengthening health systems implement a well-designed customized quality-of-care improvement framework.
Keywords

Full text: Available Collection: International databases Database: MEDLINE Type of study: Experimental Studies / Observational study Language: English Year: 2022 Document Type: Article Affiliation country: Cvr

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Type of study: Experimental Studies / Observational study Language: English Year: 2022 Document Type: Article Affiliation country: Cvr